SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-24-001322
Filing Date
2024-03-05
Accepted
2024-03-05 16:05:35
Documents
1
Period of Report
2024-03-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3116
  Complete submission text file 0001683168-24-001322.txt   4760
Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036 332-216-1147
Sunshine Biopharma, Inc (Issuer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 579 RUE LAJEUNESSE LAVAL A8 H7X 3K4
Business Address
Slilaty Steve N. (Reporting) CIK: 0001474684 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41282 | Film No.: 24720264